Skip to main content

Table 4 Results of this analysis

From: Bleeding outcomes associated with rivaroxaban and dabigatran in patients treated for atrial fibrillation: a systematic review and meta-analysis

Outcomes analyzed

OR with 95% CI

P value

I2 (%)

Any bleeding

Intra-cranial bleeding

Gastrointestinal bleeding

Stroke/SE/TIA

Venous thromboembolism

Mortality

1.28 [0.95–1.72]

2.18 [0.51–9.25]

0.98 [0.43–2.25]

0.81 [0.53–1.23]

2.06 [0.73–5.82]

1.42 [0.99–2.06]

0.11

0.29

0.97

0.32

0.17

0.06

0

0

0

0

0

38

  1. Abbreviations: SE systemic embolism, TIA transient ischemic attack, OR odds ratios, CI confidence interval